軟骨寡聚基質蛋白(COMP)重組蛋白
Recombinant Cartilage Oligomeric Matrix Protein (COMP)
MED; EDM1; EPD1; PSACH; THBS5; TSP-5; Pseudoachondroplasia,Epiphyseal Dysplasia 1,Multiple; Thrombospondin 5
- 編號RPB197Ra01
- 物種Rattus norvegicus (Rat，大鼠)相同的名稱，不同的物種。
- 來源原核表達
- 宿主E.coli
- 內毒素水平<1.0EU/µg(LAL法測定)
- 亞細胞定位分泌
- 預測分子量17.0kDa
- 實際分子量18kDa(差異分析請參閱說明書)
- 片段與標簽Arg35~Ile179 with N-terminal His Tag
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 97%
- 等電點6.8
- 應用Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請參見活性蛋白。 - 下載英文說明書 中文說明書
- 規(guī)格10μg50μg200μg1mg5mg
- 價格¥ 1061¥ 2652¥ 5304¥ 15912¥ 39780
- 欲了解實際交易價格和更多情況，請與當地經銷商聯系!
產品包裝(模擬)
產品包裝(模擬)
SDS-PAGE圖
通過ISO 9001、ISO 13485質量體系認證
序列
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復凍融。2-8°C不超過一個月，-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產生。保質期內，在適當的條件下存儲，損失率低于5%。
增值服務
相關產品
| 編號 | 適用物種：Rattus norvegicus (Rat，大鼠) | 應用(僅供研究使用，不用于臨床診斷！) |
| RPB197Ra02 | 軟骨寡聚基質蛋白(COMP)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB197Ra03 | 軟骨寡聚基質蛋白(COMP)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB197Ra01 | 軟骨寡聚基質蛋白(COMP)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB197Ra01 | 軟骨寡聚基質蛋白(COMP)多克隆抗體 | WB |
| PAB197Ra03 | 軟骨寡聚基質蛋白(COMP)多克隆抗體 | IHC |
| PAB197Ra02 | 軟骨寡聚基質蛋白(COMP)多克隆抗體 | WB; IHC; ICC; IP. |
| LAB197Ra71 | 軟骨寡聚基質蛋白(COMP)多克隆抗體(生物素標記) | WB; IHC; ICC. |
| MEB197Ra | 軟骨寡聚基質蛋白(COMP)檢測試劑盒(酶聯免疫吸附試驗法,小樣本) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| SEB197Ra | 軟骨寡聚基質蛋白(COMP)檢測試劑盒(酶聯免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| SCB197Ra | 軟骨寡聚基質蛋白(COMP)檢測試劑盒(化學發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
| LMB197Ra | 軟骨寡聚基質蛋白(COMP)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
| KSB197Ra01 | 軟骨寡聚基質蛋白(COMP)檢測試劑盒DIY材料(酶聯免疫吸附試驗法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻
| 雜志 | 參考文獻 |
| Chinese Medical Journal | Genetic analysis and serum level of cartilage oligomeric matrix protein in patients with pseudoachondroplasia [CMJ: 201082337960590] |
| BioMed Research International | Decreased Plasma COMP and Increased Plasma CTX-II Levels in a Chinese Pseudoachondroplasia Family with Novel COMP Mutation[pubmed:29104872] |
| Molecular Medicine Reports | Mori Folium water extract alleviates articular cartilage damages and inflammatory responses in monosodium iodoacetate?induced osteoarthritis rats[pubmed:29067461] |
| Archives of Rheumatology | Cartilage Oligomeric Matrix Protein Levels in Synovial Fluid in Patients With Primary Knee Osteoarthritis And Healthy Controls: A Preliminary Comparative Analysis With Serum Cartilage Oligomeric Matrix Protein[doi: 10.5606/ArchRheumatol.2017.6220] |
| Genetic Testing and Molecular Biomarkers | Cartilage Oligomeric Matrix Protein Levels in Type 2 Diabetes Associated with Primary Knee Osteoarthritis Patients[Pubmed: 30526057] |
| International Journal of Clinical and Experimental Medicine | The relationship between the serum and synovial fluid osteopontin (OPN), cartilage oligomeric matrix protein (COMP), and the severity of knee osteoarthritis …[] |
| British Journal of Medicine and Medical Research | Diagnostic Accuracy of Cartilage Oligomeric Matrix Protein (COMP), for Cartilage Damage in Rheumatoid Arthritis[] |